+39,286.4%
LOW vs GSK
+1,741.1%
+37,545.3%
-62.3%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.2% | -0.1% | -1.2% | -1.2% |
| 7D | -3.1% | -1.3% | -1.8% | -2.6% |
| 30D | +14.7% | +2.7% | +11.9% | +13.6% |
| 3M | +3.6% | +2.7% | +0.9% | +2.5% |
| 6M | +4.3% | +3.3% | +0.9% | +2.8% |
| YTD | -4.7% | +6.5% | -11.1% | -7.3% |
| 1Y | +0.9% | +10.7% | -9.8% | -3.3% |
| 3Y | +18.1% | +64.4% | -46.2% | -4.3% |
| 5Y | +1.5% | +46.7% | -45.2% | -15.8% |
| 10Y | +305.5% | +109.4% | +196.1% | +193.6% |
| All | +39,286.4% | +1,741.1% | +37,545.3% | +12,540.3% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling